| Literature DB >> 16356122 |
Barry I Hudson1, Thoralf Wendt, Loredana G Bucciarelli, Ling Ling Rong, Yoshifumi Naka, Shi Fang Yan, Ann Marie Schmidt.
Abstract
The major consequence of long-term diabetes is the increased incidence of disease of the vasculature. Of the underlying mechanisms leading to disease, the accumulation of advanced glycation end products (AGEs), resulting from the associated hyperglycemia, is the most convincing. Interaction of AGEs with their receptor, RAGE, activates numerous signaling pathways leading to activation of proinflammatory and procoagulatory genes. Studies in rodent models of macro- and microvascular disease have demonstrated that blockade of RAGE can prevent development of disease. These observations highlight RAGE as a therapeutic target for treatment of diabetic vascular disease. Antioxid. Redox Signal. 7, 1588-1600.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16356122 DOI: 10.1089/ars.2005.7.1588
Source DB: PubMed Journal: Antioxid Redox Signal ISSN: 1523-0864 Impact factor: 8.401